Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Red-Cell Aplasia, Pure

lenalidomide has been researched along with Red-Cell Aplasia, Pure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfinito, F; Avilia, S; Catalano, L; Cerchione, C; Cerciello, G; Pane, F; Picardi, M; Pisano, I; Risitano, AM1
Childs, R; Costello, R; Korde, N; Kwok, M; Landgren, O; Loeliger, K; Maric, I; Mo, C; Noel, P; Poon, A; Silver, S; Simakova, O; Sloand, E; Young, N; Zhang, Y; Zingone, A1

Other Studies

2 other study(ies) available for lenalidomide and Red-Cell Aplasia, Pure

ArticleYear
Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).
    Annals of hematology, 2015, Volume: 94, Issue:3

    Topics: Adult; Aged; Chromosome Deletion; Chromosomes, Human, Pair 5; Female; Humans; Lenalidomide; Male; Middle Aged; Myelodysplastic Syndromes; Red-Cell Aplasia, Pure; Thalidomide

2015
Monoclonal gammopathy-associated pure red cell aplasia.
    British journal of haematology, 2016, Volume: 173, Issue:6

    Topics: Adult; Aged; Bone Marrow; Dexamethasone; Diagnosis, Differential; Female; Humans; Immunoglobulins; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasma Cells; Red-Cell Aplasia, Pure; Reticulocyte Count; Reticulocytes; Thalidomide; Young Adult

2016